Filed Pursuant to Rule 424(b)(2) Registration No. 333-138510 September 14, 2007 Pricing Supplement No. 2, Dated September 14, 2007 (to Prospectus dated December 1, 2006, as supplemented by Prospectus Supplement dated March 19, 2007) Central Hudson Gas & Electric Corporation $140,000,000 Medium-Term Notes, Series F Principal Amount: $33,000,000 Issue Price: 100% Settlement Date (Original Issue Date): September 19, 2007 Maturity Date (Stated Maturity): September 1, 2017 Type of Note: |X| Fixed Rate Note |_| Zero Coupon Note Form: |X| Book-Entry |_| Definitive Certificates Authorized denominations: $1,000 and integral multiples thereof CUSIP No: 15361G AR6 Interest Rate: 6.028% per annum Interest Payment Dates: May 1 and November 1, and at maturity Record Dates: April 15 and October 15 Initial Interest Payment Date: May 1, 2008 Redemption Terms (at option of the issuer): |X| Not redeemable prior to Stated Maturity |_| Redeemable in accordance with the following terms: Repayment Terms (at option of the holder): |X| Not repayable prior to Stated Maturity |_| Repayable in accordance with the following terms: Sinking Fund Provisions: |X| None |_| Applicable in accordance with the following terms: Agents and Principal Amounts placed: Banc of America Securities LLC $11,000,000 J.P. Morgan Securities Inc. $11,000,000 KeyBanc Capital Markets Inc. $11,000,000 Agent acting in capacity indicated below: |X| As Agents Banc of America Securities LLC J.P. Morgan Securities Inc. KeyBanc Capital Markets Inc. | | As Principal The notes are being offered at the Issue Price set forth above. Agents' Commission (based on Principal Amounts placed) as follows: Banc of America Securities LLC $68,750 J.P. Morgan Securities Inc. $68,750 KeyBanc Capital Markets Inc. $68,750 Net proceeds to issuer (before expenses): $32,793,750 Additional Terms: None THE NOTES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAVE ANY OF THESE ORGANIZATIONS DETERMINED THAT THIS PRICING SUPPLEMENT OR THE APPLICABLE PROSPECTUS SUPPLEMENT OR PROSPECTUS IS ACCURATE OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.